CCCC
C4 Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
CCCC Profile
C4 Therapeutics, Inc.
A developer of novel therapies for cancer and other diseases using its proprietary Cell Selection and Engineering (CSE) platform
Biological Technology
10/07/2015
10/02/2020
NASDAQ Stock Exchange
110
12-31
Common stock
490 Arsenal Way, Suite 200, Watertown, MA 02472
--
C4 Therapeutics, Inc., was incorporated in Delaware on October 7, 2015. The company is a biopharmaceutical company dedicated to harnessing the body's natural regulation of protein levels to develop new therapeutic drug candidates to target and destroy disease-causing proteins to treat cancer, neurodegenerative diseases and other diseases.